TheProfitWatch

TOVX - Theriva Biologics, Inc.

Day 1m 10m 60m PreMarket Market AfterHours Gap
0.31 0.0 (0.52%) 0.0 (0.33%) 0.0 (0.0%) 0.0 (0.52%) --- 0.0 (0.52%) --- ---

Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Market

Earnings & Ratios

Basic EPS:
-1.93
Diluted EPS:
-1.93
Basic P/E:
-0.1591
Diluted P/E:
-0.1591
RSI(14) 1m:
52.02
VWAP:
0.31
RVol:
0.0195

Events

Period Kind Movement Occurred At

Related News